In a recent public meeting, FDA and pharma industry officials met to discuss the standards and architecture required for companies to successfully comply with the Drug Supply ...
The FDA’s recent draft guidance document pushes back enforcement for the Drug Supply Chain Security Act’s product identifier deadline. But experts warn that nothing has really...
A chain is only as strong as its weakest link. This is becoming clear to the pharmaceutical industry as it struggles to comply with FDA regulations that will require the electronic...
